Frequent use of nonsteroidal anti-inflammatory drugs (NSAIDs) has been shown to reduce the risk of colorectal adenomas in randomized trials. We examined the persistence of the protective effect after the cessation of randomized aspirin treatment and whether it is affected by the duration and frequency of subsequent NSAID use
The Aspirin/Folate Polyp Prevention Trial found that aspirin, but not folic acid, reduced recurrence...
Considerable evidence supports the effectiveness of aspirin for chemoprevention of colorectal cancer...
Thesis (Ph.D.)--University of Washington, 2017-06Substantial experimental and epidemiological eviden...
BACKGROUND: Randomised trials have shown that aspirin reduces the short-term risk of recurrent color...
Abstract Background Beneficial effects of aspirin and non-aspirin nonsteroidal anti-inflammatory dru...
Background: Although many experimental, epidemiologic, and clinical studies have suggested that aspi...
Considerable evidence supports the effectiveness of aspirin for chemoprevention of colorectal cancer...
Background: Previous studies have shown that aspirin and other non-steroidal anti-inflammatory drugs...
BACKGROUND: The preventive role of non-steroid anti-inflammatory drugs (NSAIDs) and aspirin, in part...
International audienceBackground Aspirin inhibits colorectal carcinogenesis. In a randomised double-...
Considerable evidence supports the effectiveness of aspirin for chemoprevention of colorectal cancer...
Aspirin has been shown to protect against colorectal neoplasms, however the optimal chemopreventive ...
Background High-dose aspirin (>= 500 mg daily) reduces long-term incidence of colorectal cancer, but...
There is increasing evidence to suggest that acetylsalicylic acid (ASA) and other nonsteroidal anti-...
Background. The association between the use of nonsteroidal antiinflammatory drugs (NSAID) and large...
The Aspirin/Folate Polyp Prevention Trial found that aspirin, but not folic acid, reduced recurrence...
Considerable evidence supports the effectiveness of aspirin for chemoprevention of colorectal cancer...
Thesis (Ph.D.)--University of Washington, 2017-06Substantial experimental and epidemiological eviden...
BACKGROUND: Randomised trials have shown that aspirin reduces the short-term risk of recurrent color...
Abstract Background Beneficial effects of aspirin and non-aspirin nonsteroidal anti-inflammatory dru...
Background: Although many experimental, epidemiologic, and clinical studies have suggested that aspi...
Considerable evidence supports the effectiveness of aspirin for chemoprevention of colorectal cancer...
Background: Previous studies have shown that aspirin and other non-steroidal anti-inflammatory drugs...
BACKGROUND: The preventive role of non-steroid anti-inflammatory drugs (NSAIDs) and aspirin, in part...
International audienceBackground Aspirin inhibits colorectal carcinogenesis. In a randomised double-...
Considerable evidence supports the effectiveness of aspirin for chemoprevention of colorectal cancer...
Aspirin has been shown to protect against colorectal neoplasms, however the optimal chemopreventive ...
Background High-dose aspirin (>= 500 mg daily) reduces long-term incidence of colorectal cancer, but...
There is increasing evidence to suggest that acetylsalicylic acid (ASA) and other nonsteroidal anti-...
Background. The association between the use of nonsteroidal antiinflammatory drugs (NSAID) and large...
The Aspirin/Folate Polyp Prevention Trial found that aspirin, but not folic acid, reduced recurrence...
Considerable evidence supports the effectiveness of aspirin for chemoprevention of colorectal cancer...
Thesis (Ph.D.)--University of Washington, 2017-06Substantial experimental and epidemiological eviden...